These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18710420

  • 21. Physiologic pacing in patients with obstructive sleep apnea: a prospective, randomized crossover trial.
    Krahn AD, Yee R, Erickson MK, Markowitz T, Gula LJ, Klein GJ, Skanes AC, George CF, Ferguson KA.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):379-83. PubMed ID: 16412864
    [Abstract] [Full Text] [Related]

  • 22. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F, Mautone G.
    Drugs Exp Clin Res; 2002 Jan 17; 28(1):27-35. PubMed ID: 12073765
    [Abstract] [Full Text] [Related]

  • 23. Subjective sleepiness in heart failure patients with sleep-related breathing disorder.
    Wang HQ, Chen G, Li J, Hao SM, Gu XS, Pang JN, Fu XH.
    Chin Med J (Engl); 2009 Jun 20; 122(12):1375-9. PubMed ID: 19567156
    [Abstract] [Full Text] [Related]

  • 24. Modified uvulopalatopharyngoplasty for the treatment of obstructive sleep apnea-hypopnea syndrome: resection of the musculus uvulae.
    Shin SH, Ye MK, Kim CG.
    Otolaryngol Head Neck Surg; 2009 Jun 20; 140(6):924-9. PubMed ID: 19467416
    [Abstract] [Full Text] [Related]

  • 25. Nasal surgery for snoring in patients with obstructive sleep apnea.
    Li HY, Lee LA, Wang PC, Chen NH, Lin Y, Fang TJ.
    Laryngoscope; 2008 Feb 20; 118(2):354-9. PubMed ID: 18000468
    [Abstract] [Full Text] [Related]

  • 26. [Decongestant nasal spray. Results of a rhinomanometric double-blind study].
    Maranta CA, Simmen D.
    Schweiz Med Wochenschr; 1996 Nov 02; 126(44):1875-80. PubMed ID: 8984600
    [Abstract] [Full Text] [Related]

  • 27. [Improving wound healing after nose surgery by combined administration of xylometazoline and dexpanthenol].
    Kehrl W, Sonnemann U.
    Laryngorhinootologie; 2000 Mar 02; 79(3):151-4. PubMed ID: 10763172
    [Abstract] [Full Text] [Related]

  • 28. Comparison of clinical and polysomnographic characteristics of non-obese and obese patients with obstructive sleep apnea.
    Chierakul N, Chaipattarapol C, Ruttanaumpawan P, Nana A, Naruman C, Tangchityongsiva S.
    J Med Assoc Thai; 2007 Nov 02; 90 Suppl 2():48-53. PubMed ID: 19230424
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazoline and placebo.
    Cogo A, Chieffo A, Farinatti M, Ciaccia A.
    Arzneimittelforschung; 1996 Apr 02; 46(4):385-8. PubMed ID: 8740084
    [Abstract] [Full Text] [Related]

  • 30. A randomised controlled trial of nasal decongestant to treat obstructive sleep apnoea in people with cervical spinal cord injury.
    Wijesuriya NS, Eckert DJ, Jordan AS, Schembri R, Lewis C, Meaklim H, Booker L, Brown D, Graco M, Berlowitz DJ.
    Spinal Cord; 2019 Jul 02; 57(7):579-585. PubMed ID: 30760846
    [Abstract] [Full Text] [Related]

  • 31. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
    Nussbaumer-Ochsner Y, Latshang TD, Ulrich S, Kohler M, Thurnheer R, Bloch KE.
    Chest; 2012 Jan 02; 141(1):131-138. PubMed ID: 21659435
    [Abstract] [Full Text] [Related]

  • 32. Effect of xylometazoline nasal spray on nasal conductance in subjects with coryza.
    Hamilton LH.
    J Otolaryngol; 1981 Apr 02; 10(2):109-16. PubMed ID: 6165826
    [Abstract] [Full Text] [Related]

  • 33. Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI.
    Caenen M, Hamels K, Deron P, Clement P.
    Rhinology; 2005 Sep 02; 43(3):205-9. PubMed ID: 16218514
    [Abstract] [Full Text] [Related]

  • 34. Respiratory and sleep effects of remifentanil in volunteers with moderate obstructive sleep apnea.
    Bernards CM, Knowlton SL, Schmidt DF, DePaso WJ, Lee MK, McDonald SB, Bains OS.
    Anesthesiology; 2009 Jan 02; 110(1):41-9. PubMed ID: 19104169
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection.
    Eccles R, Pedersen A, Regberg D, Tulento H, Borum P, Stjärne P.
    Am J Rhinol; 2007 Jan 02; 21(1):40-5. PubMed ID: 17283559
    [Abstract] [Full Text] [Related]

  • 36. Impact of endoscopic sinus surgery on sleep quality in patients with chronic nasal obstruction due to nasal polyposis.
    Tosun F, Kemikli K, Yetkin S, Ozgen F, Durmaz A, Gerek M.
    J Craniofac Surg; 2009 Mar 02; 20(2):446-9. PubMed ID: 19276823
    [Abstract] [Full Text] [Related]

  • 37. First-choice treatment in mild to moderate obstructive sleep apnea: single-stage, multilevel, temperature-controlled radiofrequency tissue volume reduction or nasal continuous positive airway pressure.
    Ceylan K, Emir H, Kizilkaya Z, Tastan E, Yavanoglu A, Uzunkulaoglu H, Samim E, Felek SA.
    Arch Otolaryngol Head Neck Surg; 2009 Sep 02; 135(9):915-9. PubMed ID: 19770425
    [Abstract] [Full Text] [Related]

  • 38. Nasal corticosteroids for children with snoring.
    Alexopoulos EI, Kaditis AG, Kalampouka E, Kostadima E, Angelopoulos NV, Mikraki V, Skenteris N, Gourgoulianis K.
    Pediatr Pulmonol; 2004 Aug 02; 38(2):161-7. PubMed ID: 15211701
    [Abstract] [Full Text] [Related]

  • 39. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
    Latshang TD, Nussbaumer-Ochsner Y, Henn RM, Ulrich S, Lo Cascio CM, Ledergerber B, Kohler M, Bloch KE.
    JAMA; 2012 Dec 12; 308(22):2390-8. PubMed ID: 23232895
    [Abstract] [Full Text] [Related]

  • 40. [Temperature and humidity profile of the paranasal sinuses before and after mucosal decongestion by xylometazolin].
    Keck T, Leiacker R, Schick M, Rettinger G, Kühnemann S.
    Laryngorhinootologie; 2000 Dec 12; 79(12):749-52. PubMed ID: 11199458
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.